FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
Stefan D. Anker, MD, PhD
Mahir Karakas, MD, PhD, MBA
Impact of Barostim on Heart Failure Hospitalization
Jacob Abraham, MD
Managing Patients With AAV in the Rheumatology Clinic
Andreas Kronbichler, MD
Bernhard Hellmich, MD
Don't Miss It! Rapid & Accurate AAV Diagnosis
Silke R. Brix, MD, MRCP, SCPR
Tailoring Treatment for Optimal Outcomes in Patients With AAV
Preserving Renal Function in AAV: From Novel Therapies to Practice-Changing Strategies
June 06, 2025
Vienna
Elevating Care for Patients With Severe Renal Disease in AAV
Revolutionizing IgAN Care in the Era of Precision Medicine: Diagnostic Approaches, Evolving Guidelines, and Novel Therapies
June 05, 2025
No Patient Left Behind! Advancing CKD-Associated Pruritus Care
Kieran McCafferty, MD
Maurizio Gallieni, MD
Pulmonary Hypertension: Diagnosis, Management, and Updates – Chairperson’s Perspective
Vallerie V. McLaughlin, MD
Unmasking IgAN: From Suspicion to Timely Diagnosis
Jörg Latus, MD
Chee Kay Cheung, MBCHB, MRCP, PHD
Cardiorenal Collaboration: Escape the Treatment Trap
The Changing Paradigm of Treating MASLD/MASH: At the Crossroads of Hepato-Cardiometabolic Care – Chair’s Perspective
Naim Alkhouri, MD, FAASLD, DABOM
Finally, I Can Take a Break from My Itch! Optimizing CKD-aP Treatment
Advances in IgAN Care From Kidney Week
Sydney Tang, MBBS, MD
Optimizing Outcomes in Patients With IgAN: Novel Therapies and Evolving Guidelines
Jürgen Floege, MD
Jonathan Barratt, PhD